Recombinant human thrombopoietin does not promote platelet engraftment in newly diagnosed multiple myeloma patients following autologous stem cell transplantation

Abstract To evaluate the effect of recombinant human thrombopoietin (rhTPO) on platelet engraftment after autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma (NDMM) patients. Clinical data of 40 NDMM patients who underwent high-dose melphalan conditioning and ASCT were an...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Ruiqi Wang, Jing Cai, Ziqi Chen, Hao Tian, Dan Cong, Yuansong Bai, Wenlong Zhang
Format:	Artigo
Jezik:	Inglês
Izdano:	Nature Portfolio 2025-02-01
Serija:	Scientific Reports
Teme:	Recombinant human thrombopoietin Newly diagnosed multiple myeloma Autologous hematopoietic stem cell transplantation Hematopoietic reconstitution
Online dostop:	https://doi.org/10.1038/s41598-025-89535-7
Oznake:	Označite Brez oznak, prvi označite!